HALEOS LABS
|
The Current P/E Ratio of HALEOS LABS is 28.62.
| Share Price | ₹1,456.0 | Nov 02,2026 |
| Market Cap | ₹436.8 Cr | |
| Earnings-TTM | ₹15.3 Cr | TTM-Consolidated Results |
| Price/Earnings | 28.62x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of HALEOS LABS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹436.8 Cr] as on Nov 02,2026
(/) Earnings [ ₹15.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 28.62x ]
Thus, for HALEOS LABS , the investors are currently willing to pay 28.62 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of HALEOS LABS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of HALEOS LABS over the last five years.
Historical PE (Price/Earnings) ratio chart of HALEOS LABS
PE Ratio Performance Analysis for HALEOS LABS
- HALEOS LABS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 16.35x.
- HALEOS LABS 's operated at median p/e ratio of 16.24x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HALEOS LABS 's p/e ratio peaked in Mar2024 at 22.57x.
- HALEOS LABS 's p/e ratio hit its five-year low in Mar2022 of 8.3x.
How does HALEOS LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| HALEOS LABS | 15.26 | 28.62 | 436.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,037.20 | 38.52 | 425,150.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 91.03 | 266,265.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 83.99 | 176,300.0 |
| CIPLA LTD | 2,868.29 | 39.21 | 112,474.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 41.44 | 114,351.0 |
| MANKIND PHARMA LTD | 2,249.69 | 45.48 | 102,315.0 |
| LUPIN LTD | 5,551.01 | 16.57 | 92,007.4 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 27.51 | 123,591.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 26.33 | 97,756.7 |
| LAURUS LABS LTD | 1,333.75 | 93.98 | 125,352.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs HALEOS LABS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 16.57x |
| Max industry PE | 93.98x |
| Median industry PE | 39.21x |
| Average industry PE | 48.43x |
You may also like the below Video Courses